Belgium· BE-AMP-SAM320783-00
Tetraspan 10 % 100 mg/ml
A hydroxyethylstarch product containing hydroxyethyl starch, registered in Belgium by B. Braun Melsungen. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Hydroxyethylstarch is registered in 5 of 19 countries.
Countries holding a registration under ATC B05AA07 (hydroxyethylstarch), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Hydroxyethylstarch · ATC B05AA07
5 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Hydroxyethyl Starch
- Manufacturer
- B. Braun Melsungen
- Country
- Belgium (BE)
- ATC code
- B05AA07
- ATC class
- Hydroxyethylstarch
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2581999
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
71 interactions on record for hydroxyethylstarch.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxyethylstarch · interactions on record
71 records
- 4 severe
- 67 moderate
Most severe, free to view
- DolutegravirJ05AJ03severe
- DolutegravirJ05AX12severe
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydroxyethylstarch in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc8229af-9aea-4bdb-8a44-eefdd2b56a18 GET /v1/drugs/dc8229af-9aea-4bdb-8a44-eefdd2b56a18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Tetraspan 10 % 100 mg/ml",
"name_fr": "Tetraspan 10 % 100 mg/ml",
"name_nl": "Tetraspan 10 % 100 mg/ml",
"amp_code": "SAM320783-00",
"strengths": [
"100.0000",
"0.2000",
"0.6700",
"0.3000",
"3.2700",
"6.2500",
"0.3700"
],
"pack_count": 2,
"substances": [
"Hydroxyethyl Starch",
"Magnesium Chloride Hexahydrate",
"Malic Acid",
"Potassium Chloride",
"Sodium Acetate Trihydrate",
"Sodium Acetate",
"Sodium Chloride",
"Calcium Chloride Dihydrate",
"Calcium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Hydroxyethylstarch",
"authorisation_numbers": [
"BE320783"
]
}See everything about hydroxyethylstarch.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.